Summary
This Form 8-K filing from WellPoint, Inc. (which later became Elevance Health) on March 7, 2008, primarily details executive compensation decisions made by the Compensation Committee of the Board of Directors on March 3, 2008. The report outlines the 2008 salaries, stock option grants, restricted stock unit grants, and target annual incentive plan percentages for key executive officers, including Angela F. Braly and Wayne S. DeVeydt. Investors should note the specific details of the stock option and restricted stock unit grants, including vesting schedules and performance conditions. The stock options have a three-year vesting period, while restricted stock units have vesting tied to performance metrics like Return on Equity and may have additional performance conditions related to the 2008 fiscal year. The annual incentive plan is heavily weighted towards adjusted diluted Earnings Per Share, with smaller components for Member Health Index and Service Excellence, offering potential payouts up to 260% of target.
Key Highlights
- 1Details 2008 compensation for executive officers, including salaries, stock options, and restricted stock units.
- 2Stock option grants vest in six equal semi-annual installments over three years, starting September 3, 2008.
- 3Restricted Stock Unit (RSU) grants for Angela F. Braly and Wayne S. DeVeydt have vesting conditions tied to the company's Return on Equity (ROE) performance in 2008 compared to 2007.
- 4The 2008 Annual Incentive Plan is primarily performance-based, with 90% weighting on adjusted diluted Earnings Per Share (EPS).
- 5Maximum payout for the Annual Incentive Plan can reach 260% of the target percentage for top performance.
- 6Filed on March 7, 2008, reporting events from March 3, 2008, indicating a focus on compensation planning for the upcoming year.
- 7The filing includes the Form of Restricted Stock Unit Grant Agreement as an exhibit.